Page 64 - Annual Report
P. 64

HONG KONG ACADEMY OF MEDICINE
                   香港醫學專科學院
                   CONSOLIDATED STATEMENT OF CASH FLOWS
                   FOR THE YEAR ENDED 31 DECEMBER 2020



                                                                  Note           2020            2019
                                                                                  HK$            HK$
                   Operating activities
                     Deficit for the year                                   (11,014,534)     (5,345,938)
                     Adjustments for:
                       Depreciation                                         13,636,940      20,435,419
                       Interest income                                        (887,310)       (455,347)
                       Dividend income from other financial assets            (288,537)     (2,071,670)

                   Operating cash flows before changes in
                     working capital                                         1,446,559      12,562,464

                       Decrease/(increase) in inventories                        8,972          (2,987)
                       Decrease in prepayment, deposits and other
                         receivables                                         3,522,540       2,044,928
                       Increase/(decrease) in receipts in advance              116,210         (20,960)
                       (Decrease)/increase in accruals and other
                         payables                                            (4,565,538)      390,972

                   Net cash generated from operating activities                528,743      14,974,417

                   Investing activities
                     Purchase of property, plant and equipment              (11,085,736)     (7,132,250)
                     Proceeds from disposal of other financial assets         22,088,933     18,269,750
                     Placement of time deposits                             (20,071,651)     (10,287,628)
                     Interest received                                         887,310        455,347
                     Dividend received from other financial assets             288,537       1,013,197

                   Net cash (used in)/generated from investing
                      activities                                             (7,892,607)     2,318,416

                   Net (decrease)/increase in cash and cash
                      equivalents                                            (7,363,864)     17,292,833

                   Cash and cash equivalents at 1 January                   31,336,600      14,043,767

                   Cash and cash equivalents at 31 December        14       23,972,736      31,336,600











                   The notes on pages 9 to 35 form part of these consolidated financial statements.






                                                            8





          62   HKAM Annual Report 2021
   59   60   61   62   63   64   65   66   67   68   69